A number of high cost drugs, devices, procedures and products have been excluded from the scope of the national tariff of payment by results . Following the re-organisation of the NHS these drugs are commissioned by:
NHS National Tariff Payment System for 2025/26 is available here
A summary of PbR excluded from tariff drugs commissioned by ICB or NHSE is available here (2024-25)
A detailed list of medicines directly commissioned by NHS England is available here - (Version 20.0 2025-26)
NHS England are the responsible commissioners for the management of the Cancer Drugs Fund. For details of the CDF (updated April 2025) - click here
A list of technologies with approved Patient Access Schemes is available here
The Manual - this is a technical document describing the prescribed specialised services, some of these are directly commissioned by NHS England and some by ICBs (updated March 2023)
Commissioning intentions - this serves as notice to all providers of specialised services in England of changes and priorities for the coming year
A significant proportion of high cost drugs excluded from tariff are commissioned by Derbyshire in line with NICE Technology Appraisals.
Biologic algorithms for use across Derbyshire are listed below:
Speciality |
Last updated |
Cardiology | |
Primary hypercholesterolaemia and mixed dyslipidaemia | May 2023 |
Dermatology | |
Atopic Dermatitis |
October 2024 |
Psoriasis |
April 2024 |
Alopecia Areata | July 2024 |
Gastroenterology |
|
Crohn's Disease |
July 2023 |
Ulcerative Colitis |
February 2024 |
ITP | |
Chronic immune (idiopathic) or refractory chronic thrombocytopenic purpura | April 2023 |
Neurology | |
Migraine | November 2023 |
Sodium oxybate | May 2023 |
Ophthalmology | |
Age-Related Macular Degeneration (ARMD) | January 2024 |
Diabetic Macular Oedema (DMO) | January 2024 |
Macular Oedema due to BRVO/CRVO | January 2024 |
Non-Infectious Posterior Uveitis | May 2023 |
Osteoporosis | |
Severe Osteoporosis | December 2024 |
Rheumatology | |
Ankylosing Spondylitis | November 2023 |
Psoriatic Arthritis | November 2023 |
Moderate Rheumatoid Arthritis | August 2021 |
Severe Rheumatoid Arthritis | April 2021 |